Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North Africa.
INSERM UMR_S975 (formerly UMR_S679), Hôpital de la Salpêtrière, Paris cedex 13, France. alexis.brice@upmc.fr
S
S
Lesage
C
C
Condroyer
N
N
Hecham
M
M
Anheim
S
S
Belarbi
E
E
Lohman
F
F
Viallet
P
P
Pollak
M
M
Abada
A
A
Dürr
M
M
Tazir
A
A
Brice
D000293:Adolescent; D000328:Adult; D000352:Africa, Northern / Q000208:ethnology; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005962:Glucosylceramidase / Q000235:genetics*; D006801:Humans; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010300:Parkinson Disease / Q000208:ethnology* / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D012307:Risk Factors; D055815:Young Adult
C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases; D005962:Glucosylceramidase